{
    "eid": "2-s2.0-85152349935",
    "title": "Medical Therapy in Angle Closure Glaucoma",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Angle closure",
        "Effectiveness",
        "Glaucoma",
        "Glaucoma medications",
        "Hypotensive medications",
        "IOP lowering mechanism",
        "Medical therapy",
        "Side effect"
    ],
    "authors": [
        "Prin Rojanapongpun",
        "Visanee Tantisevi"
    ],
    "citedby-count": 0,
    "ref-count": 64,
    "ref-list": [
        "Mydriasis and increased intraocular pressure",
        "Anterior segment morphology after acute primary angle closure treatment: A randomised study comparing iridoplasty and medical therapy",
        "To compare argon laser peripheral iridoplasty (ALPI) against systemic medications in treatment of acute primary angle-closure: Mid-term results",
        "Efficacy and safety of argon laser peripheral Iridoplasty and systemic medical therapy in Asian patients with acute primary angle closure: A meta-analysis of randomized controlled trials",
        "Plateau Iris in Asian subjects with primary angle closure Glaucoma",
        "Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure",
        "Comparison of the effects of 0.5% timolol maleate, 2% carteolol hydrochloride, and 0.3% metipranolol on intraocular pressure and perimetry findings and evaluation of their ocular and systemic effects",
        "Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: Advantages in clinical practice",
        "Efficacy and safety of tafluprost 0.0015%-retrospective analysis of real-world data from the Philippines",
        "Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: A preliminary study",
        "Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma",
        "Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma",
        "Meta-analysis of the efficacy and safety of Latanoprost Monotherapy in patients with angle-closure Glaucoma",
        "Comparison of the efficacy and safety of bimatoprost and timolol for treatment of chronic angle closure glaucoma",
        "Comparative evaluation of bimatoprost monotherapy in primary chronic angle closure and primary open angle glaucoma eyes: A three-year study",
        "Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360 degrees synechial angle-closure glaucoma: A preliminary study",
        "Intraocular pressure-lowering effect and safety of travoprost 0.004% and latanoprost 0.005% for the treatment of chronic angle closure glaucoma",
        "Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma",
        "Meta-analysis of randomized controlled trials comparing latanoprost with other glaucoma medications in chronic angle-closure glaucoma",
        "Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face: A preliminary study",
        "Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients",
        "Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma",
        "Side effects associated with prostaglandin analog therapy",
        "Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost",
        "Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy",
        "Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost",
        "Factors related to prostaglandin-associated Periorbitopathy in Glaucoma patients",
        "Evaluating off-label uses of acetazolamide",
        "Bilateral angle closure glaucoma induced by sulphonamide-derived medications",
        "Bilateral acetazolamide-induced choroidal effusion following cataract surgery",
        "Acute bilateral angle-closure glaucoma and choroidal effusion associated with acetazolamide administration after cataract surgery",
        "Irreversible corneal decompensation in patients treated with topical dorzolamide",
        "Influence of dorzolamide on corneal endothelium",
        "Effects of brimonidine on aqueous humor dynamics in human eyes",
        "Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty. Cochrane Database Syst",
        "Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy",
        "Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure",
        "Efficacy of brimonidine 0.2 per cent as adjunctive therapy to beta-blockers: A comparative study between POAG and CACG in Asian eyes",
        "The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use",
        "Brimonidine hypersensitivity when switching between 0.2% and 0.15% formulations",
        "Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy",
        "Effect of pilocarpine on anterior chamber angles",
        "Pilocarpine induced acute angle closure",
        "Post-miosis changes in the anterior chamber structures in primary and lens-induced secondary chronic angle-closure glaucoma",
        "Short-and long-term safety of glaucoma drugs",
        "Intravenous hypertonic urea in the management of angle closure glaucoma",
        "Medical management of angle closure glaucoma",
        "Mannitol in critical care and surgery over 50+ years: A systematic review of randomized controlled trials and complications with meta-analysis",
        "Efficacy and safety of intravenous injection of lidocaine in the treatment of acute primary angle-closure glaucoma: A pilot study",
        "Modulation of aqueous humor outflow facility by the rho kinase-specific inhibitor Y-27632 [published correction appears in invest Ophthalmol Vis Sci 2001 Jul;42(8):1690]",
        "Phase 2 randomized clinical study of a rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension",
        "Fixed-dose combination of AR-13324 and latanoprost: A double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension [published correction appears in Br J Ophthalmol. 2016 Jul;100(7):1016]",
        "Correction to: Safety and efficacy of Ripasudil in Japanese patients with Glaucoma or ocular hypertension: 3-month interim analysis of ROCK-J, a post-marketing surveillance study",
        "Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension",
        "New glaucoma medications: Latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost",
        "Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans",
        "Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma",
        "\u03949-Tetrahydrocannabinol and Cannabidiol differentially regulate intraocular pressure",
        "Marihuana smoking and intraocular pressure",
        "Medical use of cannabis for glaucoma",
        "Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery",
        "Use of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": []
}